NSCLC patients undergoing SBRT have been reported to show increased levels of CD8+ T cells and interferon-γ (IFN-γ), and decreased levels of inhibitory T reg cells [18]. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.